Skip to main content
Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

5. References

  1. Trujillo J, Yee GC, Haines S. Diabetes Mellitus. In: DiPiro JT, Yee GC, Posey L, Haines ST, Nolin TD, Ellingrod V. DiPiro J.T., & Yee G.C., & Posey L, & Haines S.T., & Nolin T.D., & Ellingrod V(Eds.),Eds. Joseph T. DiPiro, et al.eds. Pharmacotherapy: A Pathophysiologic Approach, 12e. McGraw Hill; 2023. Accessed August 28th, 2023. https://accesspharmacy-mhmedical-com.ezproxy.lib.utexas.edu/content.aspx?bookid=3097§ionid=269398080 
  2. Samson SL, Vellanki P, Blonde L, et. al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm- 2023 update. Endocr Pract. 2023 May;29(5):305-340.
  3. American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment. Diabetes Care. 2023;46 (Suppl 1):S140-157.
  4. Weinstock RS. General principles of insulin therapy in diabetes mellitus. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed August 28th, 2023.)
  5. Weinstock RS. Management of blood glucose in adults with type 1 diabetes mellitus. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed August 28th, 2023.)
  6. Levitsky LL, Misra M. Insulin therapy for children and adolescents with type 1 diabetes mellitus. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed August 28th, 2023.)
  7. Wexler JW. Insulin therapy in type 2 diabetes mellitus. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed August 28th, 2023.)
  8. American Diabetes Association. 6. Glycemic targets: Standards of medical care in diabetes – 2023. Diabetes Care. 2023;46 (Suppl 1): s97-s110. 
  9. American Diabetes Association. 13. Older adults: Standards of medical care in diabetes – 2023. Diabetes Care. 2023;46 (Suppl 1): s216-s229.  
  10. American Diabetes Association. 14. Children and adolescents: Standards of medical care in diabetes – 2023. Diabetes Care. 2023;46 (Suppl 1)S230-S253.
  11. IBM Micromedex® DRUGDEX® (electronic version). IBM Watson Health, Greenwood Village, Colorado, USA. Available at: https://www-micromedexsolutions-com.libproxy.uthscsa.edu/ (cited: September 6, 2023).
  12. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2021. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed September 6, 2023.
  13. Insulin aspart (Fiasp®) package insert. NovoNordisk, June 2023.
  14. Insulin aspart (NovoLog®) package insert. Novo Nordisk, February 2023.
  15. Insulin glulisine (Apidra®) package insert. Sanofi-Aventis, July 2023.
  16. Insulin lispro (Admelog®) package insert. Sanofi-Aventis, November 2020.
  17. Insulin lispro (Humalog®) package insert. Eli Lilly, August 2023.
  18. Insulin lispro (Lyumjev®) package insert. Eli Lilly and Company, March 2023.
  19. Regular insulin (Afrezza®) package insert. MannKind Corporation, February 2023.
  20. Regular insulin (Humulin® R) package insert. Eli Lilly, January 2023.
  21. Regular insulin (Humulin® R Concentrated U 500) package insert. Eli Lilly, 
    June 2022.
  22. Regular insulin (Novolin® R) package insert. Novo Nordisk, November 2022.
  23. Insulin isophane (NPH) (Humulin® N) package insert. Eli Lilly, March 2023.
  24. Insulin isophane (NPH) (Novolin® N) package insert. Novo Nordisk, November 2022.
  25. Insulin degludec (Tresiba®) package insert. Novo Nordisk, July 2022.
  26. Insulin detemir (Levemir®) package insert. Novo Nordisk, December 2022.
  27. Insulin glargine (Basaglar®, KwikPen™, Tempo Pen™) package insert. Eli Lilly, June 2023.
  28. Insulin glargine (Lantus®, Solostar™) package insert. Sanofi-Aventis, June 2023.
  29. Insulin glargine-aglr (Rezvoglar®, Kwikpen™) package insert. Eli Lilly and Company, November 2022.
  30. Insulin glargine-yfgn (Semglee®) package insert. Mylan Specialty LP, July 2023.
  31. Insulin glargine (Toujeo®, Toujeo Max®) package insert. Sanofi-Aventis, March 2023.
  32. Insulin aspart protamine and insulin aspart (NovoLog® Mix 70/30) package insert. Novo Nordisk, February 2023.
  33. Insulin isophane (NPH) and regular (Humulin® 70/30) package insert. Eli Lilly, March 2023.
  34. Insulin isophane (NPH) and regular (Novolin® 70/30) package insert. Novo Nordisk, November 2022.
  35. Insulin lispro (Humalog® Mix 50/50) package insert. Eli Lilly, July 2023.
  36. Insulin lispro (Humalog® Mix 75/25) package insert. Eli Lilly, July 2023.
  37. Insulin glargine and lixisenatide (Soliqua® 100/33) package insert. Sanofi-Aventis, June 2022.
  38. Insulin degludec and liraglutide (Xultophy® 100/3.6) package insert. Novo Nordisk, July 2023.
  39. Melillo G. FDA approves Fiasp for children with diabetes. Am J Manag Care. January 6, 2020. Available at: www.ajmc.com/view/fda-approves-fiasp-for-children-with-diabetes. Accessed September 6, 2023.